Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Süverkrüp R[au]:

Pharmaceutical spray freeze drying. Wanning S et al. Int J Pharm. (2015)

Jet-vortex spray freeze drying for the production of inhalable lyophilisate powders. Wanning S et al. Eur J Pharm Sci. (2017)

Aerodynamic Droplet Stream Expansion for the Production of Spray Freeze-Dried Powders. Wanning S et al. AAPS PharmSciTech. (2017)

Search results

Items: 29

1.

Jet-vortex spray freeze drying for the production of inhalable lyophilisate powders.

Wanning S, Süverkrüp R, Lamprecht A.

Eur J Pharm Sci. 2017 Jan 1;96:1-7. doi: 10.1016/j.ejps.2016.08.062. Epub 2016 Sep 1.

PMID:
27593988
2.

Aerodynamic Droplet Stream Expansion for the Production of Spray Freeze-Dried Powders.

Wanning S, Süverkrüp R, Lamprecht A.

AAPS PharmSciTech. 2017 Jul;18(5):1760-1769. doi: 10.1208/s12249-016-0648-2. Epub 2016 Oct 19.

PMID:
27761706
3.

Collisions and coalescence in droplet streams for the production of freeze-dried powders.

Süverkrüp R, Eggerstedt S, Wanning S, Kuschel M, Sommerfeld M, Lamprecht A.

Colloids Surf B Biointerfaces. 2016 May 1;141:443-449. doi: 10.1016/j.colsurfb.2016.01.063. Epub 2016 Feb 17.

PMID:
26895506
4.

Pharmaceutical spray freeze drying.

Wanning S, Süverkrüp R, Lamprecht A.

Int J Pharm. 2015 Jul 5;488(1-2):136-53. doi: 10.1016/j.ijpharm.2015.04.053. Epub 2015 Apr 18. Review.

PMID:
25900097
5.

Collisions in fast droplet streams for the production of spherolyophilisates.

Süverkrüp R, Eggerstedt SN, Gruner K, Kuschel M, Sommerfeld M, Lamprecht A.

Eur J Pharm Sci. 2013 Jul 16;49(4):535-41. doi: 10.1016/j.ejps.2013.05.010. Epub 2013 May 23.

PMID:
23707544
6.

Protein spheres prepared by drop jet freeze drying.

Eggerstedt SN, Dietzel M, Sommerfeld M, Süverkrüp R, Lamprecht A.

Int J Pharm. 2012 Nov 15;438(1-2):160-6. doi: 10.1016/j.ijpharm.2012.08.035. Epub 2012 Aug 30.

PMID:
22960322
7.

Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.

Abduljalil K, Diestelhorst M, Doroshyenko O, Lux A, Steinfeld A, Dinslage S, Süverkrüp R, Fuhr U.

Eur J Clin Pharmacol. 2008 May;64(5):521-9. doi: 10.1007/s00228-007-0457-3. Epub 2008 Jan 25.

PMID:
18219479
8.

[Three conventional eye drops versus a single lyophilisate. A comparative bioavailability study].

Lux A, Dinslage S, Süverkrüp R, Maier S, Diestelhorst M.

J Fr Ophtalmol. 2005 Feb;28(2):185-9. French.

PMID:
15851952
9.

The ophthalmic lyophilisate carrier system (OLCS): development of a novel dosage form, freeze-drying technique, and in vitro quality control tests.

Süverkrüp R, Grunthal S, Krasichkova O, Maier S, Weichselbaum A, Neff B, Diestelhorst M, Dinslage S, Lux A.

Eur J Pharm Biopharm. 2004 Mar;57(2):269-77.

PMID:
15018984
10.

Bioavailability of fluorescein from a new drug delivery system in human eyes.

Steinfeld A, Lux A, Maier S, Süverkrüp R, Diestelhorst M.

Br J Ophthalmol. 2004 Jan;88(1):48-53.

11.

A comparative bioavailability study of three conventional eye drops versus a single lyophilisate.

Lux A, Maier S, Dinslage S, Süverkrüp R, Diestelhorst M.

Br J Ophthalmol. 2003 Apr;87(4):436-40.

12.

Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment.

Dinslage S, Diestelhorst M, Weichselbaum A, Süverkrüp R.

Br J Ophthalmol. 2002 Oct;86(10):1114-7.

14.
15.

Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration.

Bagli M, Süverkrüp R, Quadflieg R, Höflich G, Kasper S, Möller HJ, Langer M, Barlage U, Rao ML.

J Pharmacol Exp Ther. 1999 Nov;291(2):547-54.

PMID:
10525070
16.

Dry Drops: a new preservative-free drug delivery system.

Diestelhorst M, Grunthal S, Süverkrüp R.

Graefes Arch Clin Exp Ophthalmol. 1999 May;237(5):394-8.

PMID:
10333106
17.

Dose uniformity of ophthalmic suspensions.

Diestelhorst M, Kwon KA, Süverkrup R.

J Cataract Refract Surg. 1998 May;24(5):672-7.

PMID:
9610452
18.

Production of artificial urinary stones from natural materials and their physical properties. First results.

Heimbach D, Jacobs D, Winter P, Süverkrüp R, Hesse A.

Scand J Urol Nephrol. 1997 Feb;31(1):9-13.

PMID:
9060076
19.

[Dosage problems in suspension eyedrops].

Kwon KA, Diestelhorst M, Süverkrüp R.

Klin Monbl Augenheilkd. 1996 Aug-Sep;209(2-3):144-9. German.

PMID:
8992075
20.
21.

Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.

Bagli M, Rao ML, Höflich G, Kasper S, Langer M, Barlage U, Beneke M, Süverkrüp R, Möller HJ.

Arzneimittelforschung. 1996 Mar;46(3):247-50.

PMID:
8901143
22.
23.

[Bioequivalence of theophylline retard capsules in children and relation of metabolism to administration route].

Berdel D, Bonnacker I, Süverkrüp R, von Berg A, Buhr W.

Pneumologie. 1990 Feb;44 Suppl 1:285-6. German.

PMID:
2367391
24.

Numerical stability of pharmacokinetic deconvolution algorithms.

Süverkrüp R, Bonnacker I, Raubach HJ.

J Pharm Sci. 1989 Nov;78(11):948-54.

PMID:
2621580
25.

Renal clearance of theophylline and its major metabolites: age and urine flow dependency in paediatric patients.

Bonnacker I, Berdel D, Süverkrüp R, von Berg A.

Eur J Clin Pharmacol. 1989;36(2):145-50.

PMID:
2721539
26.

Total theophylline clearance in childhood: the influence of age-dependent changes in metabolism and elimination.

Berdel D, Süverkrüp R, Heimann G, von Berg A, Liappis N, Stühmer A.

Eur J Pediatr. 1987 Jan;146(1):41-3.

PMID:
3582403
27.

Segmentally continuous input functions in linear multicompartment systems.

Süverkrüp R.

J Pharm Sci. 1985 Feb;74(2):136-41.

PMID:
3989681
28.

Surgically affected sulfisoxazole pharmacokinetics in the morbidly obese.

Garrett ER, Süverkrup RS, Eberst K, Yost RL, O'Leary JP.

Biopharm Drug Dispos. 1981 Oct-Dec;2(4):329-65.

PMID:
7317572
29.

Discontinuous absorption processes in pharmacokinetic models.

Süverkrüp R.

J Pharm Sci. 1979 Nov;68(11):1395-400.

PMID:
512886

Supplemental Content

Loading ...
Support Center